首页|SCNN1B在卵巢癌组织中的表达及启动子区甲基化水平

SCNN1B在卵巢癌组织中的表达及启动子区甲基化水平

Expression and promoter methylation level of SCNN1B in epithelial ovarian cancer

扫码查看
目的 检测SCNN1B基因在卵巢癌及正常卵巢组织中甲基化水平,并检测SCNN1B mRNA表达水平,探讨其与卵巢癌发生、发展关系.方法 收集2019年9月至2022年12月在北京佑安医院及石家庄市人民医院行手术治疗的卵巢癌患者62例为病例组,选取65例同期因宫颈癌、子宫肌瘤或盆腔脏器脱垂行全子宫双附件切除术患者的正常卵巢组织为对照组.焦磷酸测序检测SCNN1B基因启动子区甲基化水平,荧光定量PCR(RT-qPCR)检测SCNN1B基因mRNA的表达水平.结果 与正常卵巢组织比较,卵巢癌组织中SCNN1B基因启动子区甲基化水平显著增高,而SCNN1B基因mRNA表达水平显著降低,差异均有统计学意义(P<0.05).对SCNN1B基因启动子区的甲基化水平与SCNN1B基因mRNA表达水平在卵巢癌样本中的相关性分析表明,两者之间存在显著的负相关性(r=-0.692,P<0.01).卵巢癌组织中SCNN1B基因启动子区甲基化水平、SCNN1B基因mRNA水平与患者FIGO分期相关,且还与淋巴结转移相关(P<0.05).结论 高甲基化的SCNN1B基因启动子使SCNN1B表达沉默,可能参与卵巢癌癌变和进展.
Objective To detect the mRNA expression and methylation levels of SCNNIB in the epithelial ovarian cancer tissues and normal ovarian tissue,and to analyze the relationship of them in the initiation and progression of epithelial ovarian cancer.Methods A total of 62 epithelial ovarian cancer tissues were obtained in Beijing Youan hospital and Shijiazhuang People's Hospital between September 2019 and December 2022,and contemporaneous 65 normal ovarian tissues pecimens from patients with cervical cancer,uterine leiomyoma or uterine prolapse who underwent total hysterectomy were collected as control group.The methylation levels of SCNN1B gene promoter region were investigated by pyrophosphate sequencing,and the mRNA expression levels of SCNN1B were detected by real-time quantitative PCR(RT-qPCR).Results Compared with the normal ovarian tissues,the methylation levels of SCNN1B promoter were significantly higher in the ovarian cancer tissues(P<0.05),and the mRNA expression levels of SCNN1B gene were significantly decreased in the ovarian cancer tissues(P<0.05).Pearson's correlation analysis showed that the promoter methylation levels of SCNN1B were significantly negatively correlated with the mRNA levels of SCNNIB in the ovarian cancer tissues(r=-0.692,P<0.001).Moreover,the methylation levels and mRNA expression of SCNN1B were significantly related to International Federation of Gynecology and Obstetrics(FIGO)stages and lymph node metastasis in ovarian cancer patients(P<0.05).Conclusion The decreased expression of SCNN1B due to hypermethylation of its promoter may be involved in the initiation and progression of epithelial ovarian cancer.

ovarian cancerSCNN1BMethylation

刘馨、赵健、刘青

展开 >

100069 北京市,首都医科大学附属北京佑安医院妇科

河北省石家庄市人民医院妇产科河北医科大学附属人民医院

卵巢癌 SCNN1B 甲基化

河北省医学科学研究课题计划

20231597

2024

河北医药
河北省医学情报研究所

河北医药

CSTPCD
影响因子:1.075
ISSN:1002-7386
年,卷(期):2024.46(15)